From December 14, 2022 to December 31, 2022, the company has repurchased 10,957,235 shares, representing 0.59% for CNY 124.53 million. With this, the company has completed the repurchase of 10,957,235 shares, representing 0.59% for CNY 124.53 million under the buyback announced on December 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.64 CNY | +0.57% |
|
+0.47% | -14.40% |
06-13 | China Approves Joincare's Anti-Asthma Drug | MT |
05-28 | China Approves Joincare Unit's Asthma Drug | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.40% | 2.73B | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 600380 Stock
- News Joincare Pharmaceutical Group Industry Co.,Ltd.
- Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.